• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Coronary interventions in 2020: the year in review.

作者信息

Lunardi Mattia, Gao Charlie, Hara Hironori, Ono Masafumi, Kawashima Hideyuki, Wang Rutao, Wijns William, Serruys Patrick W, Onuma Yoshinobu

机构信息

Department of Cardiology, National University of Ireland Galway (NUIG), Galway, Ireland.

出版信息

EuroIntervention. 2021 Feb 5;16(15):e1215-e1226. doi: 10.4244/EIJ-D-20-01343.

DOI:10.4244/EIJ-D-20-01343
PMID:33478939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9724941/
Abstract
摘要

相似文献

1
Coronary interventions in 2020: the year in review.2020年的冠状动脉介入治疗：年度回顾
EuroIntervention. 2021 Feb 5;16(15):e1215-e1226. doi: 10.4244/EIJ-D-20-01343.
2
[Use of percutaneous coronary vessel interventions should be increased. 400 interventions per year is a minimum capacity of decentralized services].经皮冠状动脉介入治疗的使用应增加。每年400例介入治疗是分散服务的最低能力。
Lakartidningen. 1999 Nov 10;96(45):4928-32.
3
[Interventional cardiology in Poland in the year 2012. Summary report of the Association of Cardiovascular Interventions of the Polish Cardiac Society].[2012年波兰的介入心脏病学。波兰心脏病学会心血管介入协会总结报告]
Kardiol Pol. 2013;71(11):1213-9. doi: 10.5603/KP.2013.0313.
4
Should We Postpone Elective Cardiovascular Procedures and Percutaneous Coronary Interventions During the COVID-19 Pandemic?在 COVID-19 大流行期间，我们是否应该推迟择期心血管手术和经皮冠状动脉介入治疗？
Heart Surg Forum. 2021 Jan 15;24(1):E022-E030. doi: 10.1532/hsf.3385.
5
Interventions for cardiovascular disease in women.
Womens Health (Lond). 2009 Jul;5(4):437-46. doi: 10.2217/whe.09.33.
6
Antiplatelet therapy and coronary interventions: childhood friends or permanent partners?
J Interv Cardiol. 2002 Apr;15(2):111-3. doi: 10.1111/j.1540-8183.2002.tb01042.x.
7
Renal Disease and Coronary, Peripheral and Structural Interventions.
Interv Cardiol Clin. 2020 Jul;9(3):xi-xii. doi: 10.1016/j.iccl.2020.04.001. Epub 2020 May 11.
8
The Western Denmark Heart Registry: Its Influence on Cardiovascular Patient Care.丹麦西部心脏注册研究：对心血管患者治疗的影响。
J Am Coll Cardiol. 2018 Mar 20;71(11):1259-1272. doi: 10.1016/j.jacc.2017.10.110.
9
[Review and forecast of surgical treatment for coronary artery disease].
Zhonghua Wai Ke Za Zhi. 2006 Nov 15;44(22):1515-6.
10
Excision of right coronary artery aneurysm.
J Card Surg. 2011 Jan;26(1):48-51. doi: 10.1111/j.1540-8191.2010.01130.x. Epub 2010 Oct 6.

引用本文的文献

1
Renal Arteriography via Radial Artery Access with a 125 cm Long Angiographic Catheter.经桡动脉途径使用 125cm 长造影导管行肾动脉造影。
Biomed Res Int. 2021 Apr 23;2021:5564462. doi: 10.1155/2021/5564462. eCollection 2021.

本文引用的文献

1
3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation.ULTIMATE 试验：血管内超声与血管造影指导的药物洗脱支架置入 3 年结果比较
JACC Cardiovasc Interv. 2021 Feb 8;14(3):247-257. doi: 10.1016/j.jcin.2020.10.001. Epub 2020 Oct 29.
2
Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: considerations for study conduct and endpoint determination.2019年冠状病毒病大流行对心血管临床试验的即时和长期影响：研究实施和终点确定的考量因素
EuroIntervention. 2020 Nov 20;16(10):787-793. doi: 10.4244/EIJV16I10A147.
3
Incorporating Coronary Calcification Into Pre-Test Assessment of the Likelihood of Coronary Artery Disease.将冠状动脉钙化纳入冠状动脉疾病可能性的术前评估中。
J Am Coll Cardiol. 2020 Nov 24;76(21):2421-2432. doi: 10.1016/j.jacc.2020.09.585.
4
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.替格瑞洛与氯吡格雷用于择期经皮冠状动脉介入治疗（ALPHEUS）：一项随机、开放标签、3b 期临床试验。
Lancet. 2020 Nov 28;396(10264):1737-1744. doi: 10.1016/S0140-6736(20)32236-4. Epub 2020 Nov 14.
5
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.替格瑞洛单药治疗与替格瑞洛联合阿司匹林用于非ST段抬高型急性冠状动脉综合征患者经皮冠状动脉介入治疗后：TWILIGHT-ACS研究
Eur Heart J. 2020 Oct 1;41(37):3533-3545. doi: 10.1093/eurheartj/ehaa670.
6
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease.血管内碎石术治疗严重钙化冠状动脉疾病。
J Am Coll Cardiol. 2020 Dec 1;76(22):2635-2646. doi: 10.1016/j.jacc.2020.09.603. Epub 2020 Oct 15.
7
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque.经皮冠状动脉介入治疗易损冠状动脉粥样硬化斑块
J Am Coll Cardiol. 2020 Nov 17;76(20):2289-2301. doi: 10.1016/j.jacc.2020.09.547. Epub 2020 Oct 15.
8
Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation.SYNTAX 评分 II 的再开发和验证：用于指导复杂冠状动脉疾病患者经皮与手术血运重建策略的个体化选择：多中心随机对照 SYNTAXES 试验的二次分析及外部队列验证。
Lancet. 2020 Oct 31;396(10260):1399-1412. doi: 10.1016/S0140-6736(20)32114-0. Epub 2020 Oct 8.
9
Who Has Seen Patients With ST-Segment-Elevation Myocardial Infarction? First Results From Italian Real-World Coronavirus Disease 2019.有谁见过 ST 段抬高型心肌梗死患者？意大利真实世界 2019 冠状病毒病的初步结果
J Am Heart Assoc. 2020 Oct 20;9(19):e017126. doi: 10.1161/JAHA.120.017126. Epub 2020 Sep 9.
10
Colchicine in Patients with Chronic Coronary Disease.秋水仙碱治疗慢性冠心病
N Engl J Med. 2020 Nov 5;383(19):1838-1847. doi: 10.1056/NEJMoa2021372. Epub 2020 Aug 31.